DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of “Hold” by Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given a consensus rating of “Hold” by the twelve ratings firms that are currently covering the firm, Marketbeat reports. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $27.27.

XRAY has been the subject of a number of analyst reports. Mizuho initiated coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective for the company. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, Robert W. Baird cut their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, November 8th.

DENTSPLY SIRONA Stock Up 1.3 %

Shares of NASDAQ:XRAY opened at $18.85 on Friday. The firm’s 50-day moving average is $19.36 and its two-hundred day moving average is $23.18. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60. The firm has a market capitalization of $3.75 billion, a PE ratio of -9.11, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the company posted $0.49 EPS. Analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.40%. The ex-dividend date is Friday, December 27th. DENTSPLY SIRONA’s payout ratio is currently -30.92%.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently bought and sold shares of XRAY. Natixis Advisors LLC increased its stake in DENTSPLY SIRONA by 21.5% in the second quarter. Natixis Advisors LLC now owns 17,946 shares of the medical instruments supplier’s stock valued at $447,000 after purchasing an additional 3,173 shares during the period. Victory Capital Management Inc. increased its position in DENTSPLY SIRONA by 24.8% in the 2nd quarter. Victory Capital Management Inc. now owns 43,061 shares of the medical instruments supplier’s stock valued at $1,073,000 after acquiring an additional 8,552 shares during the period. United Services Automobile Association purchased a new stake in DENTSPLY SIRONA during the 2nd quarter valued at approximately $379,000. Texas Permanent School Fund Corp lifted its position in DENTSPLY SIRONA by 262.1% during the 2nd quarter. Texas Permanent School Fund Corp now owns 158,572 shares of the medical instruments supplier’s stock worth $3,950,000 after acquiring an additional 114,779 shares during the period. Finally, American Century Companies Inc. grew its stake in shares of DENTSPLY SIRONA by 7.8% in the 2nd quarter. American Century Companies Inc. now owns 2,482,953 shares of the medical instruments supplier’s stock valued at $61,850,000 after purchasing an additional 179,119 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.